arrow
A

Anurag K. Singh

Ohio State University
H指数:49
被引数:1.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Association of Absolute Neutrophil Count With Outcomes in Patients With Head and Neck Cancer Receiving Definitive Chemoradiation

中性粒细胞绝对计数与接受根治性放化疗的头颈部癌患者预后的关联

2026-05-010
PRE
Development and External Validation of Integrated Machine Learning-Based Prognostic Model in Oropharyngeal Head and Neck Cancer Using the Systemic Inflammatory Response Index

基于系统性炎症反应指数的口咽头颈癌集成机器学习预后模型的开发与外部验证

2025-11-290
OAAI
Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Older Patients Aged 65 Years and Above with Myelofibrosis

异基因造血干细胞移植在65岁及以上骨髓纤维化患者中的疗效

2025-08-170
OAAI
Impact of transplant conditioning, NPM1 mutations, and measurable residual disease in FLT3-ITD acute myeloid leukemia

移植预处理、NPM1突变及FLT3-ITD急性髓系白血病中可测量的微小残留病的影响

2025-07-030
OAAI
Efficacy of Ruxolitinib with Corticosteroids in Idiopathic Pneumonia Syndrome Post-Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Center Experience and Systematic Review

异基因造血干细胞移植后特发性肺炎综合征中鲁索利替尼联合皮质类固醇的疗效:单中心经验与系统综述

BLOOD
IF23.1
2024-11-050
PRE
Malnutrition risk screening in adult oncology outpatients: An ASPEN systematic review and clinical recommendations

成人肿瘤门诊患者的营养不良风险筛查: ASPEN系统评价和临床建议

2024-10-164
OA
Health-related quality of life with gilteritinib vs placebo posttransplant for FLT3-ITD+ acute myeloid leukemia
2024-09-270
OAAI
Long-Term Update of NRG/RTOG 0522: A Randomized Phase 3 Trial of Concurrent Radiation and Cisplatin With or Without Cetuximab in Locoregionally Advanced Head and Neck Cancer
2023-07-017
OAAI